Berlin registry of transcatheter mitral valve interventions (BTMVI)

Berlin registry of transcatheter mitral valve interventions (BTMVI) - BTMVI

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00040210

Enrollment

2000

Registered

2026-05-05

Start date

2026-06-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mitral valve disease

Interventions

Group 1: The Berlin Registry for Transcatheter Mitral Valve Interventions (BTMVI) is a prospective registry that includes all patients undergoing TMVI at Deutsches Herzzentrum der Charité The aim of

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Mitral valve internventions for mitral valve disease

Exclusion criteria

Exclusion criteria: Under 18 years of age Lack of informed consent

Design outcomes

Primary

Measure	Time frame
Primary endpoints: Mortality and cardiac mortality Valve-related reintervention Stroke Vascular complications The primary and secondary endpoints arising from routine clinical practice will be assessed at the following time points: Peri-interventional (30 days) Mid-term follow-up (6 months to 3 years) Long-term outcome (3 to 15 years)	—

Secondary

Measure	Time frame
Secondary endpoints: Valve degeneration Patient–prosthesis mismatch Rehospitalization Stroke Myocardial infarction Pacemaker implantation Organ failure Quality of life Adaptive and maladaptive cardiac remodeling based on imaging data from routine clinical practice (echocardiography, computed tomography, magnetic resonance imaging, etc.)	—

Countries

Germany

Contacts

Public ContactAxel Unbehaun

Deutsches Herzzentrum der Charité

ship@dhzc-charite.de+49 30 450 565855

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Sep 19, 2026